A bill filed Thursday (Jan. 16) in the Arkansas Legislature would prohibit pharmacy benefit managers and insurance companies ...
CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.
CVS Health (CVS) reachead $51.96 at the closing of the latest trading day, reflecting a -0.35% change compared to its last close.
KSNF Joplin on MSN7h
Hawley and Warren team up against Pharmacy Benefit ManagersA Missouri lawmaker is putting the high price of medication under the microscope. “My biggest issue is these PBMs, and what ...
The insurance giant and Optum parent is forecasting a 2025 medical care ratio roughly a point above last year’s 85.5 percent.
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...
In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...
UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback